June 12 (Reuters) - Quince Therapeutics Inc QNCX.O:
QUINCE THERAPEUTICS ANNOUNCES PRICING OF UP TO $22 MILLION PRIVATE PLACEMENT OF SECURITIES
QUINCE THERAPEUTICS INC - FINANCING TO PROVIDE $11.5 MILLION UPFRONT, $10.4 MILLION FROM WARRANTS
QUINCE THERAPEUTICS INC - PROCEEDS TO FUND PHASE 3 NEAT TRIAL AND CORPORATE PURPOSES
QUINCE THERAPEUTICS INC - PROCEEDS EXPECTED TO FUND OPERATIONS INTO SECOND QUARTER 2026
Source text: ID:nBw4Lyg3Wa
Further company coverage: QNCX.O
(((( Reuters.briefs@thomsonreuters.com ;));))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。